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 Abstract 
The Glasgow Outcome Scale (GOS) was first published in 1975 by Brian Jennett and 
Michael Bond, and, with over 4,000 citations to the original paper, is the most highly cited 
outcome measure in studies of brain injury and the second most-cited paper in clinical 
neurosurgery. The original GOS and the subsequently developed extended GOS (GOSE) 
are recommended by several national bodies as the outcome measure for major trauma and 
for head injury. The enduring appeal of the GOS is linked to its simplicity, short 
administration time, reliability and validity, stability, flexibility of administration (face-to-face, 
over the telephone and by post), cost-free availability and ease of access. These benefits 
apply to other derivatives of the scale, including the Glasgow Outcome at Discharge Scale 
(GODS) and the GOS paediatric revision. The GOS was devised to provide an overview of 
outcome  and to have a focus on social recovery. Since the initial development of the GOS, 
there has been an increasing focus on the multidimensional nature of outcome after head 
injury. This Review charts the development of the GOS, its refinement and usage over the 
past 40 years, and considers its current and future roles in developing an understanding of 
brain injury. 
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 Key points 
 The Glasgow Outcome Scale (GOS) in its original and extended form assesses 
disability and social participation and is the most highly cited outcome measure in 
studies on brain injury 
 
 The GOS is widely used  as a primary outcome measure, and is recommended by 
several national bodies, including the NIH in the USA, and the Department of Health 
in the UK 
 
 The GOS can be administered in various ways: face-to-face or telephone interview, 
mail, and in inpatient settings using a modified version; this flexibility leads to high 
rates of follow-up  
 
 The GOS is freely available, simple to use and requires little training, it has been 
validated, is reliable, and adult and paediatric versions are available  
 The GOS is the most popular clinician-reported outcome assessment for randomized 
clinical trials in acute head injury, and has been used in >90% of the most 
methodologically robust trials  
 Extensive use of the GOS over 40 years has led to interest in the development of 
composite measures that include the GOS to improve the assessment of brain injury 
outcome The early 1970s saw the emergence of an interest in quality of life after 
head injury, driven in part by concerns that improved medical care was reducing 
mortality in people with severe head injury, leaving some with long-term physical and 
mental difficulties and reduced social participation. Publication of the Glasgow Coma 
Scale in 1974 provided a reliable and practical means of assessing the level of 
consciousness and an early index of the severity of injury1. 1 year later, Bryan 
Jennett and Michael Bond published a complementary scale, the Glasgow Outcome 
Scale (GOS), designed to assess outcomes of brain injury2. The GOS was 
intentionally designed to provide an overview of outcome after brain injury, with a 
focus on social recovery. Since the initial description of the GOS, emphasis has been 
increasingly placed on the multi-dimensional nature of outcomes after head injury, 
which often comprise complex combinations of changes in emotional control, 
cognitive function and physical ability that, together with pre-injury factors and the 
post-injury environment, are associated with heterogeneity in outcome and with a 
change in outcome late after injury in a considerable  proportion of patients3–5.  
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The original article that described the GOS2 is the most highly cited outcome measure in 
studies of brain injury, with 4,308citations (Web of Science Core Collection 06.06.2016), and 
is the second most cited paper in clinical neurosurgery6. The later description of the 
extended GOS (GOSE)7 is in the top 25 cited papers on traumatic brain injury (TBI)8. The 
GOS in its original or extended form is recommended as the outcome measure to be used 
for major trauma and for head injury by, among others, the National Institute of Neurological 
Disorders and Stroke, the NIH National Institute of Child Health and Human Development 
TBI Clinical Trials Network and the Department of Health in England9–11. In the USA, the 
GOS  is the core measure used for outcome research in TBI in the Common Data Elements 
project12. The GOS has also been used by a range of diagnostic groups, although the focus 
has largely been head injury. This Review explains the background to the development of 
the GOS, its uses, impact and future potential, and how its application has evolved to meet 
the aspirations of the original authors  40 years after the original publication. 
 
 
[H1] Background of the Glasgow Outcome Scale 
During the early 1970s, outcome assessment after acute brain injury became increasingly 
focussed on quality of survival rather than the simple fact of survival. Death rates were still 
as high as 50%13–15, but improvements in intensive care, such as artificial ventilation, were 
believed to be reducing early mortality. This change led on one hand to claims of 
‘miraculous’ recoveries, but on the other hand raised concerns about increasing numbers of 
highly dependent survivors16. The prospect of long-lasting disorders of consciousness 
caused unease, leading to the publication of the seminal paper on the persistent vegetative 
state by Jennett and Plum17 in 1972. Reservations were also voiced about the subjectivity of 
claims that patients had made a ‘good recovery’. Furthermore, the fact that many patients 
with head injuries were young led to concern about the prospect of survival in the community 
for many years with an undefined level of recovery and about the use of interventions that 
might improve survival but leave patients with permanent, severe disability and poor quality 
of life. An anonymous letter published in the Lancet in 1973 expresses this18: 
…uncertainties about prognosis after severe head injury have lately been reviewed by 
Jennett. He maintains that claims about remarkable recoveries after severe head injury often 
prove to be falsely founded, closer examination of the circumstances commonly revealing 
either that the initial state was not as serious as had been thought, or that the degree of 
recovery is not as good as was recorded. In regard to recovery he makes some astringent 
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comments about the terms used (worthwhile, useful, practical), and he calls for a more 
objective scale. But that is easier said than done, because what matters is the overall social 
consequence of the combination of physical and mental sequelae. 
 
In order to assess the evidence for these views and to understand the pattern of events after 
brain injury, a system was needed that could bring together the factors that are important in 
outcome and express the summation of their effects on a structured scale. At the time, 
outcomes after brain injury were categorized with gross, descriptive and often poorly defined 
terms: examples of such categorizations include ‘dead, vegetative existence or recovery’19, 
‘dead, permanently unconscious/demented or recovered’14, or ‘persisting coma, persisting 
dementia or mental restitution’13. Although crude, these categorizations did reflect a 
realization that outcomes needed to be considered in terms of social function and 
reintegration into the community.  
An original driver for the development of a robust outcome scale was the realization that 
multicentre studies of outcomes after coma were needed to address the issue of balancing 
reductions in mortality rate with survival and quality of life7. The GOS was, therefore, 
designed and published in this context. The original scale consisted of five categories, each 
of which was described; the three most positive categories related to social function and 
return to work2 (Table 1). The scale was designed to assess disability outcomes in the 
community, with a broad concept of disability that included social participation and was later 
defined as “handicap” in the WHO 1980 classification20,21. 
 
[H1] Evolution and application of the Glasgow Outcome Scales  
[H2] Early development 
Soon after its publication, the GOS was used in two ground-breaking prospective 
international multicentre studies of head injury15 and nontraumatic coma22. In a 1978 article 
that identified head injury as a notable public health problem and emphasized the need for a 
greater understanding of outcome predictors, use of the GOS was recommended to 
neurosurgical centres worldwide to determine the effectiveness of neurosurgical 
interventions23. The GOS was welcomed and used in several other studies in the 1970s and 
early 1980s24,25, and was the main outcome measure in the US National Traumatic Coma 
Databank26 study.  
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In 1981, Jennett and colleagues7 expanded the five-point GOS into an eight-point scale —
later to become known as the GOSE —by dividing each of the Moderate, Severe Disability 
and Good Recovery categories into two: “better” and “worse”. They also performed some 
initial validation of the GOSE by comparing outcomes obtained from it with the duration of 
post-traumatic amnesia, outcome ratings given by an experienced clinician, and the results 
of cognitive assessment. Further early work assessed the validity of GOS outcomes in 
relation to cognitive function more systematically27. The GOS ratings were associated with 
cognitive test scores, but the GOSE ratings were not associated in the same way, although 
the sample was subdivided for analysis and as a result was small and might have been 
underpowered.  
 
[H2] The structured format and its administration  
Studies that assessed the reliability of the GOS and GOSE found the five-point version to be 
superior, but also identified considerable inter-rater variation in rankings for both versions of 
the scale, and systematic differences according to the background and experience of the 
assessor27–29. In 1998,  a structured format was developed for use with the original five-point 
GOS and the eight-point GOSE30. New guidelines were developed, which more explicitly 
stated the rationale for assignment of individuals to each category. Importantly, the 
structured format also provided a means of taking into account pre-injury disability by making 
explicit that the GOS should reflect change from before the head injury. Also emphasized in 
this format is the need to use the best available source of information, which can be a 
person who is close to the patient given that the patient themselves might not have insight 
into their difficulties, and guidelines are included for dealing with additional factors, such as 
multiple injuries and epilepsy. Use of this structured format improves inter-rater reliability for 
the GOS (kappa = 0.89) and GOSE (kappa = 0.85)30. A comparison of the structured format 
of the GOS and GOSE with cognitive tests revealed medium to strong correlations between 
rankings on the GOS and GOSE and scores on cognitive tests at 3–6 months after 
injury31,32. Strong correlations were also seen with self-report measures of mental well-being, 
including the Beck Depression Inventory, the Short Form Health Survey-36 (SF-36) and 
General Health Questionnaire 2831. 
Flexibility in methods of administration for assessments offers benefits such as improving 
follow-up rates. The structured format of the GOS and GOSE has been used to validate 
telephone and postal administration. High levels of agreement were seen between telephone 
and face-to face administration (test-retest GOS kappa= 0.92 and GOSE 0.92; inter-rater 
GOS kappa= 0.85 and GOSE 0.84)33. Postal versions of the GOS and the GOSE, which 
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could be completed by the person with head injury or by a proxy, also had very high test–
retest reliability (kappa= 0.94 GOS and 0.98 GOSE)34. 
[H2] The Glasgow Outcome at Discharge Scale  
The GOS was designed to assess independence in the community, but in some studies, the 
GOS and GOSE have been used in an inpatient setting. These scales are not validated for 
use in this context, but their use demonstrates a demand for an inpatient scale that enables 
comparisons with later GOS and GOSE outcomes in the community in longitudinal studies. 
An inpatient scale also has the potential to facilitate clinical decisions about discharging 
patients, especially when patients are being discharged from a non-specialist ward. The 
Glasgow Outcome at Discharge Scale (GODS) was published in 201335. This scale was 
developed from the GOSE and uses the same outcome categories, but the criteria for 
categorization are modified for the inpatient setting. Use of the GODS has shown that it can 
predict disability on the GOSE at 3 weeks after discharge with a sensitivity of 89% and 
specificity of 75%, and inter-rate reliability seems to be high (kappa = 0.98)35.  
[H2] Children’s versions 
The original GOS is frequently used to examine outcomes in children36–38, although data on 
the validity of the GOS in this context are limited. The brevity of the GOS and its ease of 
administration are considered to be advantages over other scales39, but the literature 
generally points towards benefits from using a modified version of the GOSE for children. 
In 1992, the GOS was modified specifically to assess outcomes in children in the intensive 
care unit, and a category of ‘Mild Disability’ (somewhat similar to the GOSE Lower Good 
Recovery category) was added to the original five-point scale40. Subsequently derived from 
the modified scale was the Paediatric Overall Performance Category and the Paediatric 
Cognitive Performance Category Scales. These scales are intended to be administered at 
hospital admission (baseline) and at discharge, enabling the changes in score to be 
compared with the length of stay in intensive care and the mortality. Inter-rater reliability of 
these scales seems to be high (intraclass correlation coefficient = 0.88–0.92). However, the 
validity of the scales for predicting outcomes after discharge from hospital remains unclear41.  
In 2012, the GOSE Pediatric Revision (GOSE-Peds) was developed to take into account 
developmental stages42. The GOSE-Peds uses the same eight categories as the GOSE and 
involves a structured interview that is adapted from that for the GOSE to allow for 
developmental differences. The validity of the GOSE-Peds was assessed by comparing 
rankings with those from the GOS and scores on standardized functional scales for children, 
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including the Vineland Adaptive Behaviour Scale (VABS), parental report and tests of 
general intellect and learning. The study included 159 patients aged 1 month to 17 years, 
and revealed a strong association between rankings on the GOSE-Peds and those from the 
GOS at 3 months (Spearman r = 0.87) and 6 months (Spearman r= 0.82) after injury. A 
similarly strong association was seen with the VABS (Spearman r = –0.62 at 3 months and –
0.74 at 6 months). Rankings on the GOSE-Peds tended to be more a strongly associated 
with other outcome measures than were rankings on the GOS42. Further work is required to 
confirm which scale is best in children (including comparisons of paediatric scales with the 
GOSE), and a tendency remains to use the GOSE or GOS in paediatric studies. 
 
[H2] Application and typical findings  
Outcomes determined with the GOS or GOSE at 3–12 months after severe head injury have 
a bimodal distribution: typically, >70% of patients have extreme outcomes of Good Recovery 
or Dead43. In those who survive at 1 year, approximately half of patients who had mild, 
moderate and severe head injuries are categorized as disabled by the GOS at 1 year, 5–
7 years and 10–12 years after injury4,44,45. Follow-up rates in studies that use the GOSs are 
high, an observation that holds true for large-scale clinical trials46, long term community 
follow-up studies, and unselected series that include patients with mild head injuries (which 
often have a relatively low retention at follow-up) 4,44,45. The GOSs also tend to be associated 
with higher follow-up rates than are other assessments, such as cognitive testing4,47, an 
observation that, at least in part, probably reflects their ease of administration and the range 
of validated methods of administration (face-to-face, telephone or post) as a community 
measure (GOS and GOSE) and, more recently, as an inpatient measure (GODS).  
The numbers that are sometimes attached to outcomes of the GOS, GOSE or GODS are 
rankings and must not be seen as arithmetic ‘scores’. As categorical, ordinal information, the 
scales require non-parametric approaches to statistical analyses.  
  
[H1] Criticisms   
[H2] Sensitivity and reliability  
Despite widespread use of the GOS and GOSE, they have been criticized, often in relation 
to their use in clinical trials of acute care. Most studies in which neuroprotective therapies 
are tested have used the GOS as a primary outcome measure, and the possibility that the 
sensitivity of the GOS is insufficient to detect changes has been raised as an explanation for 
uniformly negative findings42. The sensitivity of an outcome scale such as the GOS is, 
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however, directly related to the change that is considered clinically relevant, and not to its 
ability to detect effects on an impairment that are just noticeable but have no impact on 
function. 
 
Another criticism of the GOS that has been raised relates to its reliability. For example, Lu 
et al.48,49 have raised concerns about the inter-rater reliability of the GOS and GOSE, and 
the fact that misclassifications would reduce the power to detect a significant effect in clinical 
trials. These critics have suggested that early estimates of the inter-rater reliability of the 
GOS were optimistic and note that significant inter-rater variability for the GOSE was 
reported when it was used by untrained  investigators50. Inter-rater agreement has been 
improved by the development of an alternative two-step system for rating with the GOSE, 
which initially focuses on allocation to a GOS category and then involves limited questioning 
to further determine the appropriate GOSE category49. Further improvements were seen if 
raters received feedback on each case during their review. This approach complicates the 
assessment process, and a requirement for reviewer feedback might make it impractical. 
The study did not consider the impact of pre-study rater training, which could be self-
administered via the Internet and incorporate a test of competency.  
 
[H2] Dichotomization of outcomes 
Despite early criticism of the GOS for “over-compressing” survival outcome7, a convention 
developed for dichotomising the five-point GOS scale into ‘unfavourable’ (Dead, Vegetative 
or Severe Disability) or ‘favourable’ (Moderate Disability or Good Recovery) outcomes. This 
dichotomy reflects the view that independent function, rather than survival with disability that 
leaves patients dependent, is the desired outcome  because head injury is most common 
among young adults. However, several aspects of this dichotomization have been 
questioned. 
 
One drawback of the dichotomy is that it does not take into consideration the patient’s 
perception of life satisfaction, which is crucial and cannot simply be equated with 
independent function51: studies have shown that self-reported quality of life can be good in 
the face of severe disability52–54 and that the factors most strongly associated with disability 
outcomes are emotional rather than physical4,55.  
 
Dichotomizing outcomes in this way also limits comparison of outcomes between clinical 
trials. A state-of-the-science overview published in 2016 identified >180 randomized 
controlled trials published since 1980 in which interventions for managing acute head injury 
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were compared56, and the GOS or GOSE was the clinician-reported index of outcome in 
more than two thirds of these trials.56 Twenty-six of these RCTs, were defined as 
methodologically robust and the GOS/GOSE was used in 23. The analysis in many of these 
studies was based on outcome dichotomization, and the criterion for efficacy was a shift 
from unfavourable outcomes to favourable outcomes. Few studies have reported significant 
benefits of active interventions, and the failure to find an effect in any kind of acute brain 
damage despite so many studies has raised questions about aspects of trial methodology, 
including the limitations of simple dichotomization. The division between Severe Disability 
and Moderate Disability came to be seen as arbitrary, and a dichotomy at this point fails to 
acknowledge a change from Moderate Disability to Good Recovery Importantly, concerns 
were raised about whether dichotomization might be statistically inefficient, as it underuses 
the information available about shifts in the pattern of finding over the full, ordered spectrum 
of outcomes9. These disadvantages have led to the investigation of two new approaches to 
the analysis of the GOS in the past decade: the sliding dichotomy and the proportional odds 
methods. Both methods make use of statistical analyses for use with ordinal scales such as 
the GOSs. Ordinal data is presented in order of magnitude, but the size of the difference 
between points on the scale may not be the same; for example vegetative state is worse 
than severe disability which is worse than moderate disability and so on.  
 
In the sliding dichotomy analysis, outcomes are still split into two categories, but a 
favourable outcome is defined as one that is better than expected when the prognosis of 
patients at entry into the study is taken into account. This involves dividing the study 
population into subgroups according to the early severity of their injury. This is done by 
taking into account factors such as clinical and imaging findings and patient age57. The point 
of dichotomization is adjusted according to the subgroup. For example, among patients with 
a good prognosis, only Good Recovery is considered to be a favourable outcome; for 
patients with an intermediate prognosis, a favourable outcome is Moderate Disability or 
better. 
 
Proportional odds analysis has the potential to be even more informative. It exploits the full 
range of the GOS ratings to produce a single estimate of a treatment effect. All possible 
configurations of dichotomized outcomes are assessed, based on the assumption that the 
odds ratio of a favourable outcome relative to an unfavourable outcome will be similar 
regardless of where the scale is dichotomized. The analysis yields a pooled estimate, or 
common odds ratio that indicates change in outcome across the entire range of GOS ratings 
after treatment. It is possible to control statistically for the influence of factors that contribute 
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to variability in the impact of among the study population, allowing more inclusive entry 
criteria and, consequently, faster recruitment of participants. 
 
The potential benefits of ordinal statistical methods, such as sliding dichotomy and 
proportional odds analysis, were initially explored with the Rankin Scale for stroke58 before 
being applied to the GOS in spontaneous intracranial haemorrhage59 and head injury60. The 
theoretical statistical advantages of these new approaches were confirmed in simulation 
studies61 that showed substantial gains in efficiency that could allow sample sizes to be 
reduced by up to 50% without loss of statistical power. Powerful validation of the approach 
came from a retrospective study that used data from a large trial of corticosteroid treatment 
in head injury62. Dichotomous analysis of the GOS at 6 months after injury showed a non-
significant adverse effect of the treatment (OR 1.09, 95% CI 0.98–1.21, P = 0.096). Analysis 
with the proportional odds logistic regression model, however, produced a highly significant 
effect (estimated common OR 1.15, 95% CI 1.06–1.25, P = 0.0007). Similar results were 
obtained with sliding dichotomy. If using either ordinal analysis, a 2–2.5-fold gain in 
information density was achieved. Use of the GOSE can give a modest increase in efficiency 
over use of the GOS, corresponding to a further reduction in the required sample size of 3–
5%63.  
 
To date, prospective application of ordinal analyses has been crucial in only a few instances. 
However, the International Stroke Trial of thrombolysis in stroke is one example in which 
such analysis was important. The pre-specified primary dichotomized analysis indicated no 
significant treatment benefit, but the pre-specified ordinal analysis revealed a highly 
significant benefit. Meta-analysis of all trials of tissue plasminogen activator strongly 
suggests that the result of the ordinal analysis is valid64. The use of ordinal methods is 
increasing: these methods were used in 60% of stroke trials published between 2007 and 
2014, but are specified in the protocols of 15 of 16 current trials65. In head injury research 
the use of ordinal methods in analysis is one of four key recommendations made by the 
International Mission on Prognosis and Clinical Trial Design in TBI ( IMPACT ) group after 
several years of extensive research into trial methodology66 .  
 
The extra information gained by using the sliding dichotomy or proportional odds methods 
does not seem to differ consistently, and other factors influence which of these methods is 
chosen. The sliding dichotomy is more clinically appealing because the underlying concept 
of assessing  how often a patient achieves an outcome that is better than was predicted, is 
easy to communicate and comprehend. The proportional odds is theoretically more efficient 
but is also more complex and its results are  not so readily translated into clinical terms. [In 
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either case, these developments in methodology increase the value of information obtained 
from the GOS and GOSE, and are likely to extend the role of these scales in clinical 
research.  
 
[H2] Ceiling effects  
Some have argued that GOS and GOSE ratings have a low ceiling that does not adequately 
represent the range of impairment within Good Recovery categories43. For this reason, 
interest has grown in developing composite batteries that combine the GOSE with, for 
example, cognitive tests so as to increase sensitivity and the ability to detect subtle changes 
in outcome10. Composite endpoints have been used in several large-scale clinical trials in 
TBI, including studies of the impact of magnesium sulphate67  and intracranial pressure 
monitoring on functional recovery following TBI68. Despite use of a range of outcome 
measures, these trials still failed to demonstrate benefits of intervention.  A simulation in 
which the GOSE alone was compared with a composite measure that included the GOSE 
and three neuropsychological tests showed that, after adjusting for baseline prognosis, the 
two approaches had similar power to detect an effect69. The authors of this study concluded 
that cognitive testing only adds an advantage if the intervention has a larger effect on 
cognition than on global outcome. This finding has generated interest in developing sensitive 
cognitive endpoints that might be used as primary endpoints in place of the GOS and GOSE, 
but clinical studies have provided no evidence that composite endpoints are superior to the 
GOSE alone. Furthermore, attempts to combine measures in this way  need to take into 
account the fact that cognitive impairment may not be associated with changes in daily 
function.  
 
[H1] Relationships with other outcome measures 
The main alternative to the GOS or GOSE as an index of general outcome is the Disability 
Rating Scale (DRS), which focuses on  neurological symptoms and restrictions in activities 
of daily living. The DRS is a 30-point scale that uses eight questions and tends to under-
represent social participation. The DRS was originally developed to track reductions in 
disability during rehabilitation70. Some reports have suggested that the DRS is more 
sensitive to change in inpatients than is the GOS, but the absence of a validated or objective 
comparator makes this conclusion difficult to justify71. Furthermore, assessment of the GOS 
in inpatient settings is inappropriate, and similar studies in future should use the GODS35. On 
the other hand, several aspects of the DRS have been criticized. Its use requires more 
training than is needed for the GOS or GOSE, and severe disability and vegetative 
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outcomes overlap43,72. The sensitivity of the DRS has also been questioned; for example, 
comparison of the DRS and GOS in the community has shown that the GOS is more 
sensitive to treatment effects of a hypothermia intervention72. 
Other scales tend to be used in rehabilitation settings, require rater training, and take longer 
to complete than the GOS, but can provide fine-grained assessments. For example, the 
Functional Independence Measure (FIM) comprises 18 questions, each of which is 
answered on a scale of 0–8. Use of the Functional Assessment Measure (FAM) as an 
adjuvant adds a further 12 questions. However, the FIM is thought to be of limited use in 
detecting changes after patients are discharged from rehabilitation, and it lacks sensitivity to 
psychosocial disability73. 
The DRS, FIM and FAM are not strictly ordinal, as they subcategorize abilities that do not 
have an inherent rank order; for example, a score for a feeding subcategory cannot be 
ranked below a higher score in communication9. Furthermore, errors in can reduce the 
power to detect an effect, and the potential for such misclassification increases as the 
number of items being scored increases72. This effect demonstrates the trade-off in using a 
measure, such as the GODS or GOSE, that is reliable, quick to administer and requires little 
training, or other measures that provide more-detailed information about actual and potential 
disability and can indicate specific needs for intervention and rehabilitation , but are more 
time consuming, less reliable, require more lengthy training and are more difficult to 
interpret, especially when using grouped data. 
The GOSE is associated with psychological factors, such as self-esteem, stress, depression, 
anxiety and locus of control. Late after injury, psychological factors are more strongly 
associated with outcome than are injury-related physical factors4,35. Sequential and serial 
assessment of patients with the GOSE has, therefore, facilitated attempts to understand the 
relationships between emotional function, disability and change in disability over time. 
Results of these longitudinal studies indicate that some outcomes remain unchanged, but 
others are dynamic and can improve or deteriorate even ten years or more after 
injury4,35,45,74,75.  
 
Assessment of health-related quality of life (QoL) has become increasingly important in 
neurological disease. The GOSs have been described as indices of quality of life, although 
are perhaps more precisely assessments of life function, which is just one component of 
QoL. Emotional distress continues to be associated with poor functional outcome many 
years after injury74, and GOS measures correlate closely with emotional distress and QoL as 
measured with generic QoL assessments, such as the SF-36, and with the Quality of Life 
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After Brain Injury (QOLIBRI) measure, which is specific for patients with head injury.35,56 The 
strength of the association between these measures indicates excellent validity of the 
clinician rating scales in relation to patient-reported outcomes. The direction of any causal 
relationship between subjective wellbeing and global function remains to be clarified, and is 
an important issue for understanding how patients can adjust to the effects of head injury.  
 
 
[H1] International developments  
Much of the work to develop the GOSs was conducted in Glasgow, UK, but the measures 
have been used widely and in multicentre international randomized controlled trials. 
Important insights have been gained from their worldwide use.  
 
[H2] Australia  
The GOS and GOSE have been used extensively in Australian studies that assessed early 
interventions76–80 and examined the effects of genetic status75,81, psychiatric disorders82,83, 
demographics, injury severity and rehabilitation74,84-88 on outcome. The Victorian State 
Trauma Registry also involves use of the GOSE to assess outcome in general trauma 
victims, including those with TBI89.  
 
The optimal method of analysing GOSE results remains a subject of debate in Australia. In 
many studies, the scale has been dichotomized, leading to reduced sensitivity. The point of 
dichotomization has varied: in some studies of medical interventions, a GOSE ranking of 5–8 
has indicated a good outcome76-78,80, whereas in some studies of rehabilitation , rankings of 
7–8 were good outcomes74,75. Not all of these dichotomizations are necessarily sensible: 
classifying Moderate Disability as a favourable outcome when the individual has been 
unable to return to pre-injury work and social activities, for example, is arguably 
inappropriate. The use of proportional odds analysis or a sliding dichotomy to describe GOS 
and GOSE outcomes in relation to the baseline risk for the individual could address this 
issue73. However, such methods seem to have been used very little in Australia to date. [ 
 
The possibility that the GOS has low sensitivity to emotional and psychosocial effects88 has 
been addressed in Australia with the development of The Sydney Psychosocial 
Reintegration Scale. This scale is a 12-item clinician rating scale designed to measure 
psychosocial functioning in people with head injury in the domains of Occupational Activity, 
Interpersonal Relationships and Independent Living Skills90. Having undergone a rigorous 
development process, this scale has been used, predominantly in Australian studies to date, 
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to document outcome across separate domains form both the patient and close other 
perspective, and to identify predictors of outcome. It has also shown sensitivity to change in 
response to treatment91. Although it takes longer than the GOSE to administer, these 
features render the SPRS complementary to the GOSE in certain contexts92.  
 
[H2] The USA 
In the USA, the GOS has been used extensively in single-centre and multicentre 
observational studies of severe TBI, including the National Coma Data Bank and NIH-funded 
clinical trials93,94. An undisputed advantage of the GOS and GOSE for trials in severe head 
injury is its capability to grade outcome in patients who are noncommunicative, or when 
standard performance-based outcome measures are not feasible through the use of clinical 
observation and/or input from a collateral source such as a carer or relative. Trends in 
current head injury research and clinical practice in the USA support the use of the GOS and 
its extensions, such as GOSE, GODS and GOSE-Peds, for use with children. For example,  
the GOSE-Peds has been used in clinical trials of hypothermia in children42. 
 
Versions of the GOS have been included in Common Data Element resources developed, 
on the basis of recommendations by study groups, by the NIH and other US Federal 
agencies, for assessing global outcome after TBI and outcomes in specific domains, 
including cognition, behaviour and social participation12. Version 2 of the CDE specified the 
most appropriate outcome measures according to severity of TBI, age of the patient and 
phase of recovery95. The National Institute of Neurological Disorders and Stroke (NINDS) 
designated the GOSE as a ‘core’ CDE measure of global outcome of adult TBI, including 
outcomes of acute hospitalization, rehabilitation after moderate to severe head injury, mild 
TBI, and as an outcome measure in epidemiology studies. The GOSE-Peds was 
recommended as a ‘basic’ measure of global outcome of acute hospitalization and 
rehabilitation in children with moderate to severe TBI, as a ‘supplemental’ outcome measure 
for concussion and mild TBI, and as an outcome in epidemiology studies. The GOS was 
designated as a ‘supplemental’ measure for all severities and phases of recovery from adult 
head injury, implying that GOSE should be preferred. This Federal impetus towards 
standardization of outcome measures facilitates comparison between studies, and US 
investigators are now mandated to submit their data on TBI to a Federal registry, which will 
eventually facilitate meta-analysis of aggregated data sets. 
 
The GOSE was the primary measure of global outcome in the Transforming Research and 
Clinical Knowledge in TBI (TRACK-TBI) pilot96 in the USA. The project involved patients with 
acute injuries across the spectrum of severity and produced seminal studies on the 
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prediction of outcome after mild TBI. Despite uncertainty about the sensitivity of the GOSE to 
the effects of mild TBI,  Good Recovery vs Moderate to Severe Disability at 3 months was 
related to MRI predictors which were obtained approximately two weeks post-injury 97.  
 
A major area of research and clinical practice in the USA is concussion in athletes, and the 
GOSs could have a role in this context. Given the intense interest in late effects of 
concussion, such as chronic traumatic encephalopathy, the GOS or GOSE might be useful 
in conjunction with other measures for grading the long-term effects of repetitive head 
impacts in prospective studies. 
 
Also in the USA, increasing recognition that the assessment of outcomes should include the 
patient’s perspective has led to NIH-supported development of self-report measures such as 
the Neuro-QOL, which has item banks to assess everyday functioning, social participation, 
emotional status, satisfaction with life, and applied cognition. Brief and extended self-report 
measures that are derived from the item banks have produced promising data that indicate 
their reliability and validity, and have been designated as CDEs. These self-report measures 
could complement the GOSE in future research96. 
   
[H1] Current status, future uses and improvements 
Nichol and colleagues73  list five features of the ideal outcome scale for head injury: it should 
be logistically simple to administer (that is, take a short time to administer, be valid with 
different methods of administration and have clearly defined scoring); reliable; valid; stable 
(that is, sensitive and responsive with no ceiling effects); and free to administer. As 
discussed above, the GOSs meet all of these criteria, and are widely recommended as the 
main outcome measure in studies of head injury9–11. An important and often overlooked 
advantage of the GOSs are their (validated) flexibility of administration as a community 
measure (GOS/GOSE) and as an inpatient measure (GODS), in addition to their ease of 
administration. As discussed, these features are associated with high follow-up rates in 
longitudinal studies4,44. Inevitably, however, choices need to be made, and the advantages 
of brevity, modest requirement for assessor training and high reliability of the GOSs must be 
weighed against the limitations and benefits of more comprehensive and fine-grained 
assessments. 
These considerations  have stimulated efforts to combine the GOS and GOSE with other 
instruments to create multidimensional endpoints10. As discussed, interest is growing in 
developing measures that combine the global outcome of GOSE with outcomes from tests of 
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cognitive impairment and quality of life98,99. Future studies that compare global outcomes 
with such composite approaches could be informative. Important to keep in mind when 
looking for subtle effects with such measures, however, is that the GOSs assess change in 
function that results from brain injury, whereas performance on cognitive tests is strongly 
affected by sociodemographic factors, such as age, education and deprivation, and by 
motivation to perform the tests100. Nevertheless, work in this area together with a better 
understanding of the impact of factors, such as rehabilitation and the community 
environment, in the post-acute stage could improve covariate adjustment in clinical trials, 
and therefore the overall sensitivity of endpoints to brain injury.  
Currently, the GOSE should be used in preference to the GOS for two reasons. First, data 
collected for the GOSE can be collapsed to provide GOS ratings if necessary, but the 
reverse is not true. Second, the GOSE has greater sensitivity32,62. The potential of the GODS 
to aid clinical decision-making and planning at the time of discharge, particularly from 
general wards, is an avenue for further research35. 
 
[H1] Conclusions 
The GOS in its original and extended forms is the most highly cited outcome scale in studies 
of brain injury, and 40 years after its original publication, it continues to be widely 
recommended as the primary outcome measure in intervention trials. The GOSs are simple 
to use, valid and reliable, are freely available and include adult and paediatric versions. Their 
flexibility of administration facilitates high follow-up rates. The GOSE should be used in the 
community in preference to the original to improve sensitivity, and the GODS can be used in 
inpatient settings32,35,51. The GOS is also the most popular clinician-reported outcome 
assessment for randomized controlled trials in acute head injury, and its extensive use over 
the past four decades has fostered interest in the development of composite assessments 
that use the GOSE in conjunction with other validated measures to enhance the assessment 
of outcome after brain injury. Our understanding of outcome after head injury will continue to 
develop, and the GOSs look set to continue to play an important role.  
 
 
Note: The GOS, GOSE and GODS together with guidance for use and training materials are 
available without cost at the following websites: 
https://commondataelements.ninds.nih.gov/TBI.aspx#tab=Data_Standards  
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http://www.gla.ac.uk/media/media_253224_en.pdf 
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Table 1: Original proposed descriptions of GOS categories by Jennett and Bond2 
GOS Category Proposed description of category 
 
Death Ascribable to a particular incident and due to 
original brain damage. Potentially sub-
categorize deaths according to whether they 
occur before or after regaining 
consciousness to distinguish initial recovery 
from brain damage  
Persistent Vegetative State Unresponsive and speechless for weeks or 
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 months after acute brain damage. Sleep 
wake cycles return after 2–3 weeks   
Severe Disability  
(conscious but disabled) 
Dependent on daily support because of 
physical and/or mental causes 
Moderate Disability  
(disabled but independent) 
Independent in ‘daily life’ (for example, can 
use public transport and work in a sheltered 
environment). Able to maintain self-care and 
‘activities of daily living’. Considerable family 
disruption possible 
Good Recovery 
 
Resumption of normal life, although there 
may be minor neurological and psychological 
deficits. Return to work could lead to false 
impressions in either direction (for example, 
socioeconomic factors in work availability, 
attitude of past employers; included here are 
leisure interests and family relationships 
 
